Market Overview

UPDATE: Deutsche Bank Upgrades Mednax to Hold, Raises PT

Share:
Related MD
US Stock Futures Edge Lower Ahead Of ADP Report
MEDNAX Announces Acquisition of Pediatric Ear, Nose and Throat Practice in Houston
IBD 50 Endures Tough Week; Some Charts Intact, Others Not (Investor's Business Daily)

In a report published Friday, Deutsche Bank upgraded its rating on Mednax (NYSE: MD) from Sell to Hold, and raised its price target from $65.00 to $76.00.

Deutsche Bank noted, “MD's last two quarters have significantly allayed our concerns about a steeper slow-down in NICU trends. The combination of better-than-expected NICU volumes and stronger margins force us to reconsider our more cautious view on MD's earnings power. We move to Hold (from Sell), and raise our PT to $76 ($65) on higher estimates and our year-end process to roll-forward valuations off the new out-year (2014).”

Mednax closed on Thursday at $73.41.

Latest Ratings for MD

DateFirmActionFromTo
Aug 2015Stifel NicolausMaintainsBuy
May 2015Raymond JamesMaintainsOutperform
Feb 2015Stifel NicolausUpgradesHoldBuy

View More Analyst Ratings for MD
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Upgrades Analyst Ratings

 

Related Articles (MD)

View Comments and Join the Discussion!

Get Benzinga's Newsletters